[go: up one dir, main page]

HUP9803039A2 - Pharmaceutical composition for profilacting and treating obesity and it's complications - Google Patents

Pharmaceutical composition for profilacting and treating obesity and it's complications

Info

Publication number
HUP9803039A2
HUP9803039A2 HU9803039A HUP9803039A HUP9803039A2 HU P9803039 A2 HUP9803039 A2 HU P9803039A2 HU 9803039 A HU9803039 A HU 9803039A HU P9803039 A HUP9803039 A HU P9803039A HU P9803039 A2 HUP9803039 A2 HU P9803039A2
Authority
HU
Hungary
Prior art keywords
profilacting
complications
pharmaceutical composition
treating obesity
extract
Prior art date
Application number
HU9803039A
Other languages
Hungarian (hu)
Inventor
István Lelkes
István Seffer
Original Assignee
István Lelkes
István Seffer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by István Lelkes, István Seffer filed Critical István Lelkes
Priority to HU9803039A priority Critical patent/HUP9803039A2/en
Publication of HU9803039D0 publication Critical patent/HU9803039D0/en
Publication of HUP9803039A2 publication Critical patent/HUP9803039A2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Medical treatment of obesity based on 98.05% natural products and 1.95% pharmaceutical ingredients. The product is based on decomposition of fats and appetite suppression and it contains glanudlae thyreoidaue sicc., tri-iodine-tironin-acetate, pancreatine powder, titrex-hyoscyanus, passion flower extract, valerian extract, fenfluramin hydrochloride and/or clobenzorex hydrochlorid and/or fluvoxamin.
HU9803039A 1998-12-30 1998-12-30 Pharmaceutical composition for profilacting and treating obesity and it's complications HUP9803039A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9803039A HUP9803039A2 (en) 1998-12-30 1998-12-30 Pharmaceutical composition for profilacting and treating obesity and it's complications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9803039A HUP9803039A2 (en) 1998-12-30 1998-12-30 Pharmaceutical composition for profilacting and treating obesity and it's complications

Publications (2)

Publication Number Publication Date
HU9803039D0 HU9803039D0 (en) 1999-02-01
HUP9803039A2 true HUP9803039A2 (en) 2000-09-28

Family

ID=89997619

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9803039A HUP9803039A2 (en) 1998-12-30 1998-12-30 Pharmaceutical composition for profilacting and treating obesity and it's complications

Country Status (1)

Country Link
HU (1) HUP9803039A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033616B2 (en) 2000-06-30 2006-04-25 Phytopharm Plc Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use
US7501135B2 (en) 1999-10-27 2009-03-10 Conopco, Inc. Gastric acid secretion

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501135B2 (en) 1999-10-27 2009-03-10 Conopco, Inc. Gastric acid secretion
US7033616B2 (en) 2000-06-30 2006-04-25 Phytopharm Plc Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use
US7416744B2 (en) 2000-06-30 2008-08-26 Conopco, Inc. Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use

Also Published As

Publication number Publication date
HU9803039D0 (en) 1999-02-01

Similar Documents

Publication Publication Date Title
WO2002041837A3 (en) Treatment of mucositis
GB9407305D0 (en) Pharmaceutical compositions
HUP9904221A3 (en) Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia for producing pharmaceutical compositions
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
IL110045A0 (en) Pharmaceutical compositions containing oligopeptides combating aids and arc and for immune stimulation and certain such novel oligopeptides
ATE141511T1 (en) USE OF A BACTERIOCIN ANTIBIOTIC AGENT IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR TREATING STOMACH UPSET CAUSED BY HELICOBACTER PYLORI.
HRP20030046A2 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
CA2153340A1 (en) Application of riluzole in the treatment of parkinson's desease and parkinsonian syndromes
CA2213302A1 (en) Method of preventing or treating alimentary tract damage due to chemotherapy or radiation
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
AU685075B2 (en) Pharmaceutical composition for treating nicotine dependence
HUP9603607A3 (en) Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis
BG105302A (en) Means for improving cognition
MX9805705A (en) Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses.
ATE252389T1 (en) A MEDICINAL PRODUCT FOR TREATING OBESITY AND IMPROVING LIPID METABOLISM
AU5170499A (en) Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
MX9708803A (en) Diaromatic propynyl or dienyl compounds.
BG105275A (en) Tan-1057 derivatives
HK1037528A1 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
WO1996037183A3 (en) Compositions capable of masking astringent taste sensations
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
HUP9803039A2 (en) Pharmaceutical composition for profilacting and treating obesity and it's complications
WO1999050239A3 (en) Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
HK1069327A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia